PATRYS LIMITED - Announcements

0.00%

0.2¢

Market Cap $4.731M

Healthcare Biotechnology

Patrys Limited is focused on the development of its deoxymab platform of cell-penetrating... Patrys Limited is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company’s deoxymab platform is based on the deoxymab 3E10 antibody that is identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus (SLE). It has developed two humanized forms of deoxymab 3E10, both have improved activity over the original deoxymab 3E10 antibody. PAT-DX1 is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, while PAT-DX3 is a full-sized IgG antibody. In a range of pre-clinical studies, PAT-DX1 has shown an ability to kill cancer cells in cell models, human tumor explants, xenograft and orthotopic models. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. This allows specific delivery of cancer drugs to multiple types of cancer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PAB	Entitlement Offer - Letter to Ineligible Shareholders		06/08/25	217.15KB	Share
PAB	Entitlement Offer Open/Despatch Letter Eligible Shareholders		06/08/25	517.75KB	Share
PAB	Appendix 4C - Quarterly - 30 June 2025	PRICE SENSITIVE	29/07/25	473KB	Share
PAB	Entitlement Offer Prospectus	PRICE SENSITIVE	23/07/25	567.85KB	Share
PAB	Proposed issue of securities - PAB		23/07/25	21.46KB	Share
PAB	Proposed issue of securities - PAB		23/07/25	23.13KB	Share
PAB	Non-Renounceable Entitlement Offer	PRICE SENSITIVE	23/07/25	226.41KB	Share
PAB	Change of Director's Interest Notice		08/07/25	241.71KB	Share
PAB	Notification of cessation of securities - PAB		08/07/25	15.47KB	Share
PAB	Notification of cessation of securities - PAB		23/06/25	12.84KB	Share
PAB	Final Director's Interest Notices x2		23/06/25	769.71KB	Share
PAB	Initial Director's Interest Notices x2		23/06/25	602.19KB	Share
PAB	Section 708A Cleansing Statement		18/06/25	268.56KB	Share
PAB	Application for quotation of securities - PAB		18/06/25	15.89KB	Share
PAB	Proposed issue of securities - PAB		17/06/25	15.68KB	Share
PAB	Deed of Release entered into with CEO	PRICE SENSITIVE	17/06/25	213.72KB	Share
PAB	Reinstatement to Official Quotation	PRICE SENSITIVE	10/06/25	101.74KB	Share
PAB	Proposed issue of securities - PAB		10/06/25	18.59KB	Share
PAB	Proposed issue of securities - PAB		10/06/25	19.77KB	Share
PAB	Proposed issue of securities - PAB		10/06/25	15.35KB	Share
PAB	Proposed issue of securities - PAB		10/06/25	16.41KB	Share
PAB	Proposed issue of securities - PAB		10/06/25	15.69KB	Share
PAB	Successful Placement and Board Changes	PRICE SENSITIVE	10/06/25	342.17KB	Share
PAB	Suspension from Quotation	PRICE SENSITIVE	03/06/25	367.27KB	Share
PAB	Change of Registered Office and Principal Place of Business		02/06/25	157.47KB	Share
PAB	Trading Halt	PRICE SENSITIVE	30/05/25	342.15KB	Share
PAB	Appendix 4C - Quarterly - 31 March 2025	PRICE SENSITIVE	30/04/25	496.7KB	Share
PAB	Notification of cessation of securities - PAB		03/04/25	12.79KB	Share
PAB	Final Director's Interest Notice		03/04/25	234.46KB	Share
PAB	Retirement of Non-Executive Director		31/03/25	149.56KB	Share
PAB	Appendix 4D - Half Year Accounts - 31 December 2024	PRICE SENSITIVE	21/02/25	1.63MB	Share
PAB	Appendix 4C - Quarterly - 31 December 2024	PRICE SENSITIVE	30/01/25	496.34KB	Share
PAB	Change of Director's Interest Notices x3		24/12/24	757.87KB	Share
PAB	Notification of cessation of securities - PAB		24/12/24	13.29KB	Share
PAB	Patrys Receives R&D Tax Incentive Refund	PRICE SENSITIVE	16/12/24	216.51KB	Share
PAB	Results of Annual General Meeting		22/11/24	580.97KB	Share
PAB	Chair's Address and CEO Presentation to 2024 AGM		22/11/24	4.43MB	Share
PAB	Appendix 4C - Quarterly - 30 September 2024	PRICE SENSITIVE	30/10/24	504.68KB	Share
PAB	Notice of Annual General Meeting/Proxy Form		21/10/24	798.39KB	Share
PAB	Notification of cessation of securities - PAB		14/10/24	12.87KB	Share
PAB	PAT-DX1 clinical development update	PRICE SENSITIVE	02/10/24	297.97KB	Share
PAB	PAT-DX1 GMP specification testing update	PRICE SENSITIVE	20/09/24	214.86KB	Share
PAB	PAT-DX1 GMP specification testing update	PRICE SENSITIVE	29/08/24	215.02KB	Share
PAB	Appendix 4G and Corporate Governance Statement		23/08/24	800.72KB	Share
PAB	Appendix 4E and 2024 Annual Report	PRICE SENSITIVE	23/08/24	14.12MB	Share
PAB	Further update on PAT-DX1 GMP manufacturing run	PRICE SENSITIVE	29/07/24	215.48KB	Share
PAB	Appendix 4C - Quarterly - 30 June 2024	PRICE SENSITIVE	23/07/24	437.82KB	Share
PAB	Update on GMP manufacturing run of PAT-DX1	PRICE SENSITIVE	01/07/24	215.1KB	Share
PAB	Appendix 4C - Quarterly - 31 March 2024	PRICE SENSITIVE	30/04/24	528.12KB	Share
PAB	Positive preclinical data for deoxymabs in vasculitis	PRICE SENSITIVE	09/04/24	299.83KB	Share
PAB	Change of Director's Interest Notice		22/03/24	193.98KB	Share
PAB	Notification of cessation of securities - PAB		22/03/24	12.8KB	Share
PAB	Presentation to highlight broader potential of Deoxymabs		04/03/24	217.21KB	Share
PAB	Appendix 4D - Half Year Accounts - 31 December 2023	PRICE SENSITIVE	23/02/24	457.19KB	Share
PAB	Appendix 4C - Quarterly - 31 December 2023	PRICE SENSITIVE	23/01/24	517.63KB	Share
PAB	Change of Director's Interest Notice		22/12/23	247.88KB	Share
PAB	GMP Production of PAT-DX1 Next Quarter	PRICE SENSITIVE	13/12/23	217.51KB	Share
PAB	Change of Director's Interest Notices x2		29/11/23	392.63KB	Share
PAB	Notification of cessation of securities - PAB		29/11/23	21.63KB	Share
PAB	Amended Constitution		15/11/23	1.23MB	Share
PAB	Results of Annual General Meeting		15/11/23	582.64KB	Share
PAB	Chair's Address and CEO Presentation to 2023 AGM		15/11/23	8.36MB	Share
PAB	Notification of Expiry of PABOA Listed Options		13/11/23	369.9KB	Share
PAB	Patrys Receives R&D Tax Incentive Refund	PRICE SENSITIVE	08/11/23	217KB	Share
PAB	Appendix 4C - Quarterly - 30 September 2023	PRICE SENSITIVE	20/10/23	487.36KB	Share
PAB	Data to be presented at leading brain cancer conference		19/10/23	281.69KB	Share
PAB	Notice of Annual General Meeting/Proxy Form		12/10/23	712.96KB	Share
PAB	Final Director's Interest Notice		20/09/23	372.26KB	Share
PAB	Retirement of Non-Executive Director		14/09/23	218.44KB	Share
PAB	Appendix 4G and Corporate Governance Statement		28/08/23	781.65KB	Share
PAB	Appendix 4E and 2023 Annual Report	PRICE SENSITIVE	28/08/23	11.45MB	Share
PAB	Change of Director's Interest Notice		11/08/23	271.58KB	Share
PAB	Application for quotation of securities - PAB		08/08/23	24.94KB	Share
PAB	Application for quotation of securities - PAB		26/07/23	24.84KB	Share
PAB	Appendix 4C - Quarterly - 30 June 2023	PRICE SENSITIVE	26/07/23	532.25KB	Share
PAB	Notification of cessation of securities - PAB		14/07/23	21.66KB	Share
PAB	Notification of Expiry of PABO Listed Options		03/07/23	782.4KB	Share
PAB	PAT-DX1 GLP toxicology reports received	PRICE SENSITIVE	24/05/23	218.67KB	Share
PAB	Notification regarding unquoted securities - PAB		11/05/23	31.66KB	Share
PAB	Appendix 4C - Quarterly - 31 March 2023	PRICE SENSITIVE	24/04/23	522.86KB	Share
PAB	Notification of cessation of securities - PAB		18/04/23	23.59KB	Share
PAB	Two new deoxymab patents granted in the USA	PRICE SENSITIVE	17/04/23	293.01KB	Share
PAB	Updated guidance for PAT-DX1 phase 1 clinical study	PRICE SENSITIVE	31/03/23	246KB	Share
PAB	New PAT-DX3 data demonstrates synthetic lethality	PRICE SENSITIVE	14/03/23	366.75KB	Share
PAB	Appendix 4D - Half Year Accounts - 31 December 2022	PRICE SENSITIVE	24/02/23	1.27MB	Share
PAB	Application for quotation of securities - PAB		16/02/23	24.79KB	Share
PAB	Change in substantial holding		15/02/23	211.53KB	Share
PAB	Change in substantial holding		03/02/23	278.67KB	Share
PAB	Change in substantial holding		03/02/23	362.43KB	Share
PAB	Appendix 4C - Quarterly - 31 December 2022	PRICE SENSITIVE	31/01/23	566.94KB	Share
PAB	Patrys Receives R&D Tax Incentive Refund	PRICE SENSITIVE	30/01/23	216.54KB	Share
PAB	Response to ASX Price Query	PRICE SENSITIVE	14/12/22	412.59KB	Share
PAB	Investor Webinar Presentation		24/11/22	6.14MB	Share
PAB	Final Director's Interest Notice		17/11/22	369.13KB	Share
PAB	Initial Director's Interest Notice		17/11/22	338.61KB	Share
PAB	Notification regarding unquoted securities - PAB		17/11/22	28.43KB	Share
PAB	Results of Annual General Meeting		16/11/22	582.52KB	Share
PAB	Chairman's Address and CEO Presentation to 2022 AGM		16/11/22	11.39MB	Share
PAB	Patrys Appoints Dr Charmaine Gittleson as Chairman		16/11/22	251.91KB	Share
PAB	Appendix 4C - Quarterly - 30 September 2022	PRICE SENSITIVE	28/10/22	471.72KB	Share

PAB Entitlement Offer - Letter to Ineligible Shareholders
06/08/25		217.15KB	Share
PAB Entitlement Offer Open/Despatch Letter Eligible Shareholders
06/08/25		517.75KB	Share
PAB Appendix 4C - Quarterly - 30 June 2025
29/07/25	PRICE SENSITIVE	473KB	Share
PAB Entitlement Offer Prospectus
23/07/25	PRICE SENSITIVE	567.85KB	Share
PAB Proposed issue of securities - PAB
23/07/25		21.46KB	Share
PAB Proposed issue of securities - PAB
23/07/25		23.13KB	Share
PAB Non-Renounceable Entitlement Offer
23/07/25	PRICE SENSITIVE	226.41KB	Share
PAB Change of Director's Interest Notice
08/07/25		241.71KB	Share
PAB Notification of cessation of securities - PAB
08/07/25		15.47KB	Share
PAB Notification of cessation of securities - PAB
23/06/25		12.84KB	Share
PAB Final Director's Interest Notices x2
23/06/25		769.71KB	Share
PAB Initial Director's Interest Notices x2
23/06/25		602.19KB	Share
PAB Section 708A Cleansing Statement
18/06/25		268.56KB	Share
PAB Application for quotation of securities - PAB
18/06/25		15.89KB	Share
PAB Proposed issue of securities - PAB
17/06/25		15.68KB	Share
PAB Deed of Release entered into with CEO
17/06/25	PRICE SENSITIVE	213.72KB	Share
PAB Reinstatement to Official Quotation
10/06/25	PRICE SENSITIVE	101.74KB	Share
PAB Proposed issue of securities - PAB
10/06/25		18.59KB	Share
PAB Proposed issue of securities - PAB
10/06/25		19.77KB	Share
PAB Proposed issue of securities - PAB
10/06/25		15.35KB	Share
PAB Proposed issue of securities - PAB
10/06/25		16.41KB	Share
PAB Proposed issue of securities - PAB
10/06/25		15.69KB	Share
PAB Successful Placement and Board Changes
10/06/25	PRICE SENSITIVE	342.17KB	Share
PAB Suspension from Quotation
03/06/25	PRICE SENSITIVE	367.27KB	Share
PAB Change of Registered Office and Principal Place of Business
02/06/25		157.47KB	Share
PAB Trading Halt
30/05/25	PRICE SENSITIVE	342.15KB	Share
PAB Appendix 4C - Quarterly - 31 March 2025
30/04/25	PRICE SENSITIVE	496.7KB	Share
PAB Notification of cessation of securities - PAB
03/04/25		12.79KB	Share
PAB Final Director's Interest Notice
03/04/25		234.46KB	Share
PAB Retirement of Non-Executive Director
31/03/25		149.56KB	Share
PAB Appendix 4D - Half Year Accounts - 31 December 2024
21/02/25	PRICE SENSITIVE	1.63MB	Share
PAB Appendix 4C - Quarterly - 31 December 2024
30/01/25	PRICE SENSITIVE	496.34KB	Share
PAB Change of Director's Interest Notices x3
24/12/24		757.87KB	Share
PAB Notification of cessation of securities - PAB
24/12/24		13.29KB	Share
PAB Patrys Receives R&D Tax Incentive Refund
16/12/24	PRICE SENSITIVE	216.51KB	Share
PAB Results of Annual General Meeting
22/11/24		580.97KB	Share
PAB Chair's Address and CEO Presentation to 2024 AGM
22/11/24		4.43MB	Share
PAB Appendix 4C - Quarterly - 30 September 2024
30/10/24	PRICE SENSITIVE	504.68KB	Share
PAB Notice of Annual General Meeting/Proxy Form
21/10/24		798.39KB	Share
PAB Notification of cessation of securities - PAB
14/10/24		12.87KB	Share
PAB PAT-DX1 clinical development update
02/10/24	PRICE SENSITIVE	297.97KB	Share
PAB PAT-DX1 GMP specification testing update
20/09/24	PRICE SENSITIVE	214.86KB	Share
PAB PAT-DX1 GMP specification testing update
29/08/24	PRICE SENSITIVE	215.02KB	Share
PAB Appendix 4G and Corporate Governance Statement
23/08/24		800.72KB	Share
PAB Appendix 4E and 2024 Annual Report
23/08/24	PRICE SENSITIVE	14.12MB	Share
PAB Further update on PAT-DX1 GMP manufacturing run
29/07/24	PRICE SENSITIVE	215.48KB	Share
PAB Appendix 4C - Quarterly - 30 June 2024
23/07/24	PRICE SENSITIVE	437.82KB	Share
PAB Update on GMP manufacturing run of PAT-DX1
01/07/24	PRICE SENSITIVE	215.1KB	Share
PAB Appendix 4C - Quarterly - 31 March 2024
30/04/24	PRICE SENSITIVE	528.12KB	Share
PAB Positive preclinical data for deoxymabs in vasculitis
09/04/24	PRICE SENSITIVE	299.83KB	Share
PAB Change of Director's Interest Notice
22/03/24		193.98KB	Share
PAB Notification of cessation of securities - PAB
22/03/24		12.8KB	Share
PAB Presentation to highlight broader potential of Deoxymabs
04/03/24		217.21KB	Share
PAB Appendix 4D - Half Year Accounts - 31 December 2023
23/02/24	PRICE SENSITIVE	457.19KB	Share
PAB Appendix 4C - Quarterly - 31 December 2023
23/01/24	PRICE SENSITIVE	517.63KB	Share
PAB Change of Director's Interest Notice
22/12/23		247.88KB	Share
PAB GMP Production of PAT-DX1 Next Quarter
13/12/23	PRICE SENSITIVE	217.51KB	Share
PAB Change of Director's Interest Notices x2
29/11/23		392.63KB	Share
PAB Notification of cessation of securities - PAB
29/11/23		21.63KB	Share
PAB Amended Constitution
15/11/23		1.23MB	Share
PAB Results of Annual General Meeting
15/11/23		582.64KB	Share
PAB Chair's Address and CEO Presentation to 2023 AGM
15/11/23		8.36MB	Share
PAB Notification of Expiry of PABOA Listed Options
13/11/23		369.9KB	Share
PAB Patrys Receives R&D Tax Incentive Refund
08/11/23	PRICE SENSITIVE	217KB	Share
PAB Appendix 4C - Quarterly - 30 September 2023
20/10/23	PRICE SENSITIVE	487.36KB	Share
PAB Data to be presented at leading brain cancer conference
19/10/23		281.69KB	Share
PAB Notice of Annual General Meeting/Proxy Form
12/10/23		712.96KB	Share
PAB Final Director's Interest Notice
20/09/23		372.26KB	Share
PAB Retirement of Non-Executive Director
14/09/23		218.44KB	Share
PAB Appendix 4G and Corporate Governance Statement
28/08/23		781.65KB	Share
PAB Appendix 4E and 2023 Annual Report
28/08/23	PRICE SENSITIVE	11.45MB	Share
PAB Change of Director's Interest Notice
11/08/23		271.58KB	Share
PAB Application for quotation of securities - PAB
08/08/23		24.94KB	Share
PAB Application for quotation of securities - PAB
26/07/23		24.84KB	Share
PAB Appendix 4C - Quarterly - 30 June 2023
26/07/23	PRICE SENSITIVE	532.25KB	Share
PAB Notification of cessation of securities - PAB
14/07/23		21.66KB	Share
PAB Notification of Expiry of PABO Listed Options
03/07/23		782.4KB	Share
PAB PAT-DX1 GLP toxicology reports received
24/05/23	PRICE SENSITIVE	218.67KB	Share
PAB Notification regarding unquoted securities - PAB
11/05/23		31.66KB	Share
PAB Appendix 4C - Quarterly - 31 March 2023
24/04/23	PRICE SENSITIVE	522.86KB	Share
PAB Notification of cessation of securities - PAB
18/04/23		23.59KB	Share
PAB Two new deoxymab patents granted in the USA
17/04/23	PRICE SENSITIVE	293.01KB	Share
PAB Updated guidance for PAT-DX1 phase 1 clinical study
31/03/23	PRICE SENSITIVE	246KB	Share
PAB New PAT-DX3 data demonstrates synthetic lethality
14/03/23	PRICE SENSITIVE	366.75KB	Share
PAB Appendix 4D - Half Year Accounts - 31 December 2022
24/02/23	PRICE SENSITIVE	1.27MB	Share
PAB Application for quotation of securities - PAB
16/02/23		24.79KB	Share
PAB Change in substantial holding
15/02/23		211.53KB	Share
PAB Change in substantial holding
03/02/23		278.67KB	Share
PAB Change in substantial holding
03/02/23		362.43KB	Share
PAB Appendix 4C - Quarterly - 31 December 2022
31/01/23	PRICE SENSITIVE	566.94KB	Share
PAB Patrys Receives R&D Tax Incentive Refund
30/01/23	PRICE SENSITIVE	216.54KB	Share
PAB Response to ASX Price Query
14/12/22	PRICE SENSITIVE	412.59KB	Share
PAB Investor Webinar Presentation
24/11/22		6.14MB	Share
PAB Final Director's Interest Notice
17/11/22		369.13KB	Share
PAB Initial Director's Interest Notice
17/11/22		338.61KB	Share
PAB Notification regarding unquoted securities - PAB
17/11/22		28.43KB	Share
PAB Results of Annual General Meeting
16/11/22		582.52KB	Share
PAB Chairman's Address and CEO Presentation to 2022 AGM
16/11/22		11.39MB	Share
PAB Patrys Appoints Dr Charmaine Gittleson as Chairman
16/11/22		251.91KB	Share
PAB Appendix 4C - Quarterly - 30 September 2022
28/10/22	PRICE SENSITIVE	471.72KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $4.731M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$600	300K

Buyers (Bids)

No.	Vol.	Price($)
48	175507647	0.1¢

Sellers (Offers)

Price($)	Vol.	No.
0.2¢	72452478	23

View Market Depth

No.	Vol.	Price($)
48	175507647	0.001
0	0	0.000
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.002	72452478	23
0.003	2304063	4
0.004	724000	2
0.005	500000	1
0.006	300000	1

Last trade - 09.59am 13/08/2025 (20 minute delay)

PAB (ASX) Chart

PATRYS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available